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Improvement of patient compliance with the
use of Posaconazole in a BMT unit
C.C. Beukes ∗
Netcare Pretoria East Hospital, Pretoria, South Africa
Background: Posaconazole is given prophylactically because of
prolonged neutropenia and the risk of systemic fungal infections.
Posaconazole usage increased in a private hospital Bone Marrow
Transplant Unit (BMT) following a Candida parapsilosis outbreak in
theGauteng region. Thewardpharmacist noticed lowPosaconazole
compliance.
Posaconazole is an oral formulation. Patients have severe
mucositis, diarrheoa, nausea, vomiting and/or no gastric absorp-
tion. Fatty meals improve absorption. Taste is a problem and
patients refused themedication. Patients preparing for theatermiss
oral doses.In a pilot studywith 8 non-compliant patients, 5 patients
[62,5%] cultured C parapsilosis
Methods & Materials: During January and February 2013 the
ward pharmacist recorded the compliance of patients within the
BMTU. Patients using Posaconazole for longer than 1 week were
included in the study.
The number of doses missed was compared to the number of
doses that shouldhavebeen takenby thepatient andconverted into
a compliance percentage. Patients are compliant when Posacona-
zolewas takenmore than 90% of the time and non-compliantwhen
they were more than 10% non-compliant.
Change was implemented and the compliance was monitored
from July 2013 to September 2013.
Changes made to improve patient compliance:
• Change dosing regimen QID to TDS
• Only AML and ALLO transplant patients
•Anti-fungal treatment changedwhenpatient is non-compliant
• Anti-fungal treatment changed in ICU setting
• Compliance monitored by pharmacist
• Training by pharmacist for nursing staff on
o Dosing
o Absorption with food in collaboration with dietitians
o Medication interactions
The results from the two periods were compared.
Results: N=28 for Jan-Feb 2013.
-18/28 patients showed less than 90% compliance
-64.3% non-compliant
-Non-compliant patients took medication 14.1% of the time.
N=26 for July to September 2013.
-2/26 patients showed less than 90% compliance
-7.6% non-compliant
-Non-compliant patients took medication 77.5% of the time.
Conclusion:During 2012 43 patientswere diagnosedwith Can-
dida parapsilosis candidaemia compared to 11 patients diagnosed
from Jan to Sep 2013.
Improving compliance to posaconazole is critical for effective
prophylaxis. Pharmacists can play an important role in supporting
improved compliance.
http://dx.doi.org/10.1016/j.ijid.2014.03.855
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Antibiotic stewardship programs: Overcoming
barriers to successful implementation
H. Liu1,∗, H. Williams2, L. Cushinotto3
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2 Bryn Mawr Hospital, Bryn Mawr, PA, USA
3 Bryn Mawr Hospital, Bala Cynwyd, PA, USA
Background: Antibiotic stewardship programs (ASP) encour-
age appropriate antibiotic use including avoidance of unnecessarily
broad therapy. However, hospitals differ in antibiotic use and
opportunities for intervention. Bryn Mawr Hospital, a 335-bed
community teachinghospital, implemented anASP three years ago.
Useof sixdesignatedantibiotics (daysofRx / thousandpatientdays;
US$ antibiotic costs) subsequently decreased signiﬁcantly:
2010 (baseline) DOT / 1,000 pt days = 49.2 $466,978
2011 29.3 $217,447
2012 28.0 $207,586
2013 25.5 $164,600
However, the program did encounter a number of barriers to
successful implementation.
Methods & Materials: After two years, a review of ASP effec-
tiveness was conducted emphasizing problems overcome and
remaining hinderances to success. Interviews with groups sup-
porting ASP (pharmacy, information technology, hospitalists, ICU
staff, emergency department, infection control, microbiology labo-
ratory) yielded information impacting on cases reviewed, attitudes
about ASP, interventions necessary, days of antibiotic therapy
(DOT) per 1000 patient-days, cost reduction, inﬂuence on future
behavior, and impact on institutional antibiograms.
Results: Enough time for case review and interventions
(phone calls, face-to-face discussions) was a limiting factor.
Monday-Wednesday-Friday morning rounds were adequate and
a compromise with personnel availability. Use of the electronic
medical record (EMR) allowed “rounding from a distance” and
was key to effectiveness. However, antibiotic restriction or “point-
of-service” feedback for computer order entry was very limited.
Physician accessibility and “buy-in” to ASP varied — education was
easier with larger more homogeneous groups (e.g., hospitalists)
while residents rotating through were difﬁcult to access. Support
from an infection control program helped extend ASP teachings.
Measuring effectiveness was helped by pharmacy computer pro-
grams, but required careful deﬁnition of parameters. Changes in
infection prevalence (e.g., C. difﬁcile) or antibiotic resistance rates
are likely only to be evident over several years.
Conclusion: Keys to ASP effectiveness include a dedicated
team with regular rounding schedule and availability of EMR to
increase timeliness. Education is critical but difﬁcult to target and
time-consuming. A multidisciplinary focus and establishment of
program deﬁnitions and goals at the outset can avoid many prob-
lems and allow better determination of effectiveness. Hospitals
considering ASP and/or implementing an EMR can take advantage
of our ﬁndings.
http://dx.doi.org/10.1016/j.ijid.2014.03.856
